2025 annual financial data
CNS Pharmaceuticals 2025 Operating margin
CNS Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -15,986,559 USD and net income was -15,850,564 USD.
Operating cash flow was -13,811,107 USD.
Get free CNS Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -15,986,559 USD
- Net income
- -15,850,564 USD
- Operating cash flow
- -13,811,107 USD